Apoquel is available in oral tablet form in different strengths — 3.6 mg, 5.4 mg, and 16 mg. You may need to conceal the medication in food or a pill pocket to facilitate easier ingestion for ...

Apoquel is a great option for many dogs with allergic skin conditions. It works quickly to relieve symptoms and has a low risk of side effects. However, Apoquel can be expensive for some pet ...

This can significantly improve the quality of life of dogs with this condition. Some newer treatments directly target the ...

Sales of companion animal products increased by 25%, driven by growth in key franchises including Simparica Trio, flea, tick ...

Zoetis' (ZTS) higher companion animal product sales are expected to have driven revenues in the first quarter of 2024 in both ...

Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Basis for First Quarter 2024 Delivers 12% ...

These included OA pain products, Librela for dogs and Solensia for cats, dermatology products like Apoquel and Cytopoint, as well as Zoetis’ parasiticide products, such as Simparica and the ...

Zoetis (NYSE: ZTS) Q1 2024 Earnings Call May 02, 2024, 8:30 a.m. ET ...

Explore how Zoetis Inc (ZTS) achieved significant operational growth and navigated market complexities in the first quarter of 2024.

So is that the correct way to think about it? And then on derm, the company decided to start selling Apoquel Chewable through distribution. Could you maybe just talk about the factors that led to ...

Growth in the quarter was driven by the company's OA pain products, Librela for dogs and Solensia for cats, as well as its key dermatology products, Apoquel and Cytopoint. Also contributing to ...